|
Rosuvastatin Impurity 42
|
瑞舒伐他汀雜質(zhì)42
|
851443-04-4
|
|
Ursodeoxycholic acid
|
熊去氧膽酸
|
128-13-2
|
|
L-alpha-Phosphatidyl-L-serine
|
L-α-磷脂酰-L-絲氨酸
|
51446-62-9
|
|
Acetylcysteine Impurity 14
|
乙酰半胱氨酸雜質(zhì)14
|
62305-89-9
|
|
Edoxaban Impurity 54
|
依度沙班雜質(zhì)54
|
2605225-71-4
|
|
Finerenone Impurity 39
|
非奈利酮雜質(zhì)39
|
|
|
Tetracaine EP Impurity C
|
丁卡因EP雜質(zhì)C
|
71839-12-8
|
|
Nicorandil N-Oxide
|
尼可地爾氮氧化物
|
107833-98-7
|
|
Avanafil Impurity 70
|
阿伐那非雜質(zhì)70
|
32897-26-0
|
|
Clindamycin Phosphate Sulfoxide Impurity
|
克林霉素磷酸酯亞砜雜質(zhì)
|
1228573-90-7
|
|
Pyridoxine N-Oxide HCl
|
鹽酸吡哆醇N-氧化物
|
112507-12-7
|
|
Rivaroxaban Impurity 7(S-isomer)
|
利伐沙班雜質(zhì)7(S-異構(gòu)體)
|
161596-47-0
|
|
Brexpiprazole-d8
|
依匹哌唑-d8
|
1427049-21-5
|
|
Tetracaine EP Impurity B
|
丁卡因EP雜質(zhì)B
|
4740-24-3
|
|
Cefotaxime EP Impurity F
|
頭孢噻肟EP雜質(zhì)F
|
175032-97-0
|
|
Candesartan Cilexetil
|
坎地沙坦酯
|
145040-37-5
|
|
Naproxen EP Impurity G (R-Naproxen)
|
萘普生EP雜質(zhì)G (R-萘普生）
|
23979-41-1
|
|
Neomycin Sulfate EP Impurity A
|
硫酸新霉素EP雜質(zhì)A
|
3947-65-7
|
|
Rivaroxaban EP Impurity H
|
利伐沙班EP雜質(zhì)H
|
1770812-37-7
|
|
(S)-Epichlorohydrin
|
(S)-環(huán)氧氯丙烷
|
67843-74-7
|
|
Ketoprofen EP Impurity F
|
酮洛芬EP雜質(zhì)F
|
42872-30-0
|
|
Fluticasone USP related compound B
|
氟替卡松相關(guān)化合物B
|
219719-95-6
|
|
Cefuroxime Sodium EP Impurity A
|
頭孢呋辛鈉EP雜質(zhì)A
|
56271-94-4
|
|
Ganciclovir EP Impurity B
|
更昔洛韋EP雜質(zhì)B
|
194159-18-7
|
|
Epirubicin EP Impurity B
|
表柔比星EP雜質(zhì)B
|
21794-55-8
|
|
rac Cetirizine N-Oxide (Mixture of Diastereomers)
|
N-乙酰基西替利嗪 （非對(duì)映異構(gòu)體混合物）
|
1076199-80-8
|
|
Oseltamivir Impurity 57
|
奧司他韋雜質(zhì)57
|
943515-58-0
|
|
Vonoprazan Impurity 127
|
沃諾拉贊雜質(zhì)127
|
2250243-23-1
|
|
Aminophylline EP ImpurityC
|
氨茶堿EP雜質(zhì)C
|
7597-60-6
|
|
Bimatoprost Acid
|
比馬前列素C1酸
|
38344-08-0
|
|
Urapidil Impurity 5
|
烏拉地爾雜質(zhì)5
|
34661-73-9
|
|
Dapagliflozin C2 Epimer
|
達(dá)格列凈 C2 差向異構(gòu)體
|
2133407-75-5
|
|
Crisaborole Impurity 17
|
克立硼羅雜質(zhì)17
|
1187188-59-5
|
|
Kanamycin
|
卡那霉素
|
59-01-8
|
|
Levocarnitine EP Impurity B
|
左卡尼汀EP雜質(zhì)B
|
124-83-4
|
|
Febuxostat Impurity 10
|
非布索坦雜質(zhì)10
|
1239233-86-3
|
|
Chlortetracycline hydrochloride
|
鹽酸金霉素
|
64-72-2
|
|
Memantine Related Compound F HCl
|
美金剛相關(guān)化合物F 鹽酸鹽
|
356572-08-2
|
|
Dexamethasone EP Impurity E
|
地塞米松EP雜質(zhì)E
|
13209-41-1
|
|
Vortioxetine Impurity 4
|
沃替西汀雜質(zhì)4
|
1429908-35-9
|
|
Indobufen Impurity 3
|
吲哚布芬雜質(zhì)3
|
1379292-20-2
|
|
Levetiracetam Impurities 25
|
左乙拉西坦雜質(zhì)25
|
263552-76-7
|
|
Granisetron EP Impurity E
|
格拉司瓊EP雜質(zhì)E
|
76272-56-5
|
|
Voclosporin
|
伏環(huán)孢素
|
515814-01-4
|
|
Cys1-Keto-Linaclotide H2O XTFA Salt
|
Cys1-酮-利那洛肽一水合物 （XTFA鹽）
|
|
|
Sitagliptin Monophosphate Monohydrate
|
磷酸西他列汀一水合物
|
654671-77-9
|
|
Tafluprost Impurity 8
|
他氟前列素雜質(zhì)8
|
209860-88-8
|
|
Thioctic acid Impurity 3
|
硫辛酸雜質(zhì)3
|
6992-30-9
|
|
Trimethoprim EP Impurity C
|
甲氧芐啶EP雜質(zhì)C
|
29606-06-2
|
|
Sodium Fusidate Impurity 18
|
夫西地酸雜質(zhì)18
|
16391-75-6
|
|
Topiramate
|
托吡酯
|
97240-79-4
|
|
Acyclovir EP Impurity R
|
阿昔洛韋EP雜質(zhì)R
|
|
|
Vortioxetine Impurity 31
|
沃替西汀雜質(zhì)31
|
2135576-73-5
|
|
Kitol Diacetate (Mixture of Diastereomers)
|
鯨醇乙酰乙酸鹽(非對(duì)映異構(gòu)體的混合物)
|
13828-13-2
|
|
Cimetidine EP Impurity I
|
西咪替丁EP雜質(zhì)I
|
29636-87-1
|
|
Sertraline EP Impurity F
|
舍曲林EP雜質(zhì)F
|
155748-61-1
|
|
Bupivacaine N-Oxide
|
布比卡因N-氧化物
|
1346597-81-6
|
|
Candesartan Cilexetil EP Impurity G(Candesartan)
|
坎地沙坦酯EP雜質(zhì)G(坎地沙坦)
|
139481-59-7
|
|
Amphotericin B Impurity 1(Amphotericin B Methyl Ester)
|
兩性霉素雜質(zhì)1(兩性霉素B甲酯)
|
36148-89-7
|
|
Aminophylline EP ImpurityE
|
氨茶堿 EP 雜質(zhì)E
|
944-73-0
|
|
Palonosetron Impurity 5
|
帕洛諾司瓊雜質(zhì)5
|
135729-55-4
|
|
Promethazine EP Impurity C HCl
|
異丙嗪EP雜質(zhì)C鹽酸鹽
|
60113-77-1
|
|
Telmisartan EP Impurity C
|
替米沙坦EP雜質(zhì)C
|
144702-26-1
|
|
Cefaclor EP Impurity B
|
頭孢克洛EP雜質(zhì)B
|
53994-69-7
|
|
Apixaban Impurity 39
|
阿哌沙班雜質(zhì)39
|
2206825-87-6
|
|
Clenbuterol EP impurity C
|
克倫特羅EP雜質(zhì)C
|
37148-48-4
|
|
Esmolol Hydrochloride
|
鹽酸艾司洛爾
|
81161-17-3
|
|
Nicorandil Impurity 32
|
尼可地爾雜質(zhì)32
|
|
|
Tofacitinib Impurity 1
|
托伐替尼雜質(zhì)1
|
1092578-46-5
|
|
Prilocaine EP Impurity F
|
丙胺卡因EP雜質(zhì)F
|
13327-14-5
|
|
Cefradine EP Impurity E
|
頭孢拉定EP雜質(zhì)E
|
215172-75-1
|
|
Empagliflozin Impurity 50
|
恩格列凈雜質(zhì)50
|
915095-94-2
|
|
Vitamin K1 Impurity 31
|
維生素K1雜質(zhì)31
|
19274-66-9
|
|
1-Adamantanamine Hydrochloride
|
鹽酸金剛烷胺
|
665-66-7
|
|
Dihydralazine EP Impurity A
|
雙肼屈嗪EP雜質(zhì)A
|
649765-80-0
|
|
Ibuprofen Impurity 61
|
布洛芬雜質(zhì)61
|
38861-88-0
|
|
Nicorandil Impurity 25 1/2Formate 1/2Nitrate
|
尼可地爾雜質(zhì)25 1/2甲酸鹽 1/2硝酸鹽
|
|
|
Ubidecarenone Impurity 2(Coenzyme Q10)
|
癸利酮雜質(zhì)2（輔酶Q10）
|
65085-29-2
|
|
Linagliptin Impurity 52
|
利格列汀雜質(zhì)52
|
2463617-43-6
|
|
Methylprednisolone EP Impurity B
|
甲基潑尼松龍EP雜質(zhì)B
|
58636-50-3
|
|
L-(+)-Ascorbic Acid
|
L(+)-抗壞血酸
|
50-81-7
|
|
Indapamide Impurity 3
|
吲達(dá)帕胺雜質(zhì)3
|
1205-30-7
|
|
Propofol Impurity 27
|
異丙酚雜質(zhì)27
|
20170-32-5
|
|
Cys1-Linaclotide Imidazolidione Impurity XTFA Salt
|
Cys1-利那洛肽IMD雜質(zhì) （XTFA鹽）
|
|
|
Cilostazol related compound C
|
西洛他唑相關(guān)物質(zhì)C
|
865792-18-3
|
|
Calcitriol Impurity 26
|
骨化三醇雜質(zhì)26
|
57102-09-7
|
|
Ticagrelor Impurity 12 (Mixture of Diastereomers)
|
替卡格雷雜質(zhì)12（非對(duì)映體混合物）
|
1644461-85-7
|
|
Ceftazidime EP Impurity E
|
頭孢他啶EP雜質(zhì)E
|
102772-66-7
|
|
Alendronic Acid Impurity 3
|
阿侖膦酸雜質(zhì)3
|
73858-59-0
|
|
Cefazolin EP Impurity E(Cefazolin USP RC E)
|
頭孢唑啉EP雜質(zhì)E(頭孢唑啉USP相關(guān)物質(zhì)E)
|
29490-19-5
|
|
Voriconazole
|
伏立康唑
|
137234-62-9
|
|
Sodium Valproate EP Impurity F
|
丙戊酸鈉EP雜質(zhì)F
|
2430-27-5
|
|
Verapamil Hydrochloride
|
鹽酸維拉帕米
|
152-11-4
|
|
Ciprofloxacin EP Impurity F
|
環(huán)丙沙星EP雜質(zhì)F（鹽酸鹽）
|
226903-07-7
|
|
Fluvastatin EP Impurity A Sodium Salt(and enantiomer)
|
氟伐他汀EP雜質(zhì)A鈉鹽（對(duì)映異構(gòu)體）
|
93957-58-5
|
|
Labetalol EP Impurity F HCl
|
拉貝洛爾EP雜質(zhì)F鹽酸鹽
|
96441-14-4
|
|
Salicylic acid Impurity 12
|
水楊酸雜質(zhì)12
|
546-74-7
|
|
Landiolol Impurity 33
|
蘭地洛爾雜質(zhì)33
|
144256-12-2
|
|
Piperacillin Impurity 18
|
哌拉西林雜質(zhì)18
|
64844-70-8
|
|
Lacosamide-d3 (Acetyl-d3)
|
拉科酰胺-d3（乙?；?d3）
|
175481-36-4
|